These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 11027299)

  • 1. A conserved mechanism of retrovirus restriction in mammals.
    Towers G; Bock M; Martin S; Takeuchi Y; Stoye JP; Danos O
    Proc Natl Acad Sci U S A; 2000 Oct; 97(22):12295-9. PubMed ID: 11027299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single amino acid changes in the murine leukemia virus capsid protein gene define the target of Fv1 resistance.
    Kozak CA; Chakraborti A
    Virology; 1996 Nov; 225(2):300-5. PubMed ID: 8918916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation and characterization of a stable full-length ecotropic murine leukemia virus molecular clone that produces novel phenotypes to Fv1 restriction.
    Bae EH; Park SH; Park SM; Park JW; Lim MS; Jung YT
    J Microbiol Biotechnol; 2008 Apr; 18(4):799-804. PubMed ID: 18467880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Post-entry restriction of retroviral infections.
    Towers GJ; Goff SP
    AIDS Rev; 2003; 5(3):156-64. PubMed ID: 14598564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of the regions of Fv1 necessary for murine leukemia virus restriction.
    Bishop KN; Bock M; Towers G; Stoye JP
    J Virol; 2001 Jun; 75(11):5182-8. PubMed ID: 11333899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction of N-tropic mutant porcine endogenous retrovirus infectivity by human tripartite motif-containing 5-isoform alpha.
    Lee J; Cho YD; Heo YK; Kwon Y; Kim DG; Choi BS; Kim SS; Kim YB
    Transplant Proc; 2011 Sep; 43(7):2774-8. PubMed ID: 21911161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complex determinants within the Moloney murine leukemia virus capsid modulate susceptibility of the virus to Fv1 and Ref1-mediated restriction.
    Ulm JW; Perron M; Sodroski J; C Mulligan R
    Virology; 2007 Jul; 363(2):245-55. PubMed ID: 17343889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression levels of Fv1: effects on retroviral restriction specificities.
    Li W; Yap MW; Voss V; Stoye JP
    Retrovirology; 2016 Jun; 13(1):42. PubMed ID: 27342974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific packaging of spliced retroviral vector transcripts lacking the Psi-region.
    Pambalk K; Hohenadl C; Salmons B; Günzburg WH; Renner M
    Biochem Biophys Res Commun; 2002 Apr; 293(1):239-46. PubMed ID: 12054590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evolution of the retroviral restriction gene Fv1: inhibition of non-MLV retroviruses.
    Yap MW; Colbeck E; Ellis SA; Stoye JP
    PLoS Pathog; 2014 Mar; 10(3):e1003968. PubMed ID: 24603659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic reshuffling reconstitutes functional expression cassettes in retroviral vectors.
    Tabotta W; Klein D; Hohenadl C; Salmons B; Günzburg WH
    J Gene Med; 2001; 3(5):418-26. PubMed ID: 11601755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retroviral restriction factors Fv1 and TRIM5alpha act independently and can compete for incoming virus before reverse transcription.
    Passerini LD; Keckesova Z; Towers GJ
    J Virol; 2006 Mar; 80(5):2100-5. PubMed ID: 16474118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fv1-like restriction of N-tropic replication-competent murine leukaemia viruses in mCAT-1-expressing human cells.
    Aagaard L; Mikkelsen JG; Warming S; Duch M; Pedersen FS
    J Gen Virol; 2002 Feb; 83(Pt 2):439-442. PubMed ID: 11807237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retroviral capsid determinants of Fv1 NB and NR tropism.
    Stevens A; Bock M; Ellis S; LeTissier P; Bishop KN; Yap MW; Taylor W; Stoye JP
    J Virol; 2004 Sep; 78(18):9592-8. PubMed ID: 15331691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Positional cloning of the mouse retrovirus restriction gene Fv1.
    Best S; Le Tissier P; Towers G; Stoye JP
    Nature; 1996 Aug; 382(6594):826-9. PubMed ID: 8752279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rhesus monkey model for fetal gene transfer: studies with retroviral- based vector systems.
    Tarantal AF; O'Rourke JP; Case SS; Newbound GC; Li J; Lee CI; Baskin CR; Kohn DB; Bunnell BA
    Mol Ther; 2001 Feb; 3(2):128-38. PubMed ID: 11237669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Consensus structural models for the amino terminal domain of the retrovirus restriction gene Fv1 and the murine leukaemia virus capsid proteins.
    Taylor WR; Stoye JP
    BMC Struct Biol; 2004 Jan; 4():1. PubMed ID: 14715087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lentiviral vectors pseudotyped with murine ecotropic envelope: increased biosafety and convenience in preclinical research.
    Schambach A; Galla M; Modlich U; Will E; Chandra S; Reeves L; Colbert M; Williams DA; von Kalle C; Baum C
    Exp Hematol; 2006 May; 34(5):588-92. PubMed ID: 16647564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cloning of a new murine endogenous retrovirus, MuERV-L, with strong similarity to the human HERV-L element and with a gag coding sequence closely related to the Fv1 restriction gene.
    Bénit L; De Parseval N; Casella JF; Callebaut I; Cordonnier A; Heidmann T
    J Virol; 1997 Jul; 71(7):5652-7. PubMed ID: 9188643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of murine leukemia virus restriction in mammals.
    Besnier C; Ylinen L; Strange B; Lister A; Takeuchi Y; Goff SP; Towers GJ
    J Virol; 2003 Dec; 77(24):13403-6. PubMed ID: 14645596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.